We demonstrated that the mRNA level of NAT10 in PBMC from patients with new onset AS was significantly decreased than that in healthy controls (HC), rheumatoid arthritis (RA) and SLE, and decreased NAT10 negatively correlated with the activity of AS. The gene discussed is NAT10; the disease is systemic lupus erythematosus.